What is the role of the sleeve gastrectomy in the surgical treatment of morbid obesity?
Background: Laparoscopic sleeve gastrectomy (SG) is a relatively new procedure that is gaining wide acceptance and represents an innovative new approach to the surgical management of morbid obesity. Our purpose is to evaluate the SG as a surgical bariatric procedure.
Methods: We conducted a literature review on “PubMed” based on all publications related to SG since 2000 to July 30, 2014.
Results: The complication rate after SG varies in the literature, ranging from 0 to 29 %. The most feared complication after SG is leakage on the staple line, occurring in 0–7 % of cases. The mortality rate reported varies between 0 and 3.3 %. No consensus has developed on the types of stapling used or the methods of strengthening the staple line. SG may aggravate and be responsible for gastroesophageal reflux disease (GERD). SG improves comorbidities in more than 50 % after 5 years.
Conclusions: SG can be proposed as a surgical technique at first intension in patients not having GERD.